Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

L.A. McKeown

December 12, 2012

Advertisement

Scientific Statement Reviews Current Antithrombotic Options in PAD

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Meta-analysis Looks at Bypass vs. Endovascular Therapy for Femoropopliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content